Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2012 Apr;6(2):140-6.
doi: 10.1016/j.molonc.2012.01.010. Epub 2012 Feb 6.

Cancer biomarkers

N Lynn Henry  1 , Daniel F Hayes
Affiliations
Review

Cancer biomarkers

N Lynn Henry et al. Mol Oncol. 2012 Apr.

Abstract

Biomarkers have many potential applications in oncology, including risk assessment, screening, differential diagnosis, determination of prognosis, prediction of response to treatment, and monitoring of progression of disease. Because of the critical role that biomarkers play at all stages of disease, it is important that they undergo rigorous evaluation, including analytical validation, clinical validation, and assessment of clinical utility, prior to incorporation into routine clinical care. In this review we address key steps in the development of biomarkers, including ways to avoid introducing bias and guidelines to follow when reporting results of biomarker studies.

PubMed Disclaimer

References

    1. Allegra, C.J. , Jessup, J.M. , Somerfield, M.R. , Hamilton, S.R. , Hammond, E.H. , Hayes, D.F. , McAllister, P.K. , Morton, R.F. , Schilsky, R.L. , 2009. American Society of Clinical Oncology provisional clinical opinion: testing for KRAS gene mutations in patients with metastatic colorectal carcinoma to predict response to anti-epidermal growth factor receptor monoclonal antibody therapy. J. Clin. Oncol.. 27, 2091–2096. - PubMed
    1. Allred, D.C. , 2008. Commentary: hormone receptor testing in breast cancer: a distress signal from Canada. Oncologist. 13, 1134–1136. - PubMed
    1. Baggerly, K.A. , Morris, J.S. , Coombes, K.R. , 2004. Reproducibility of SELDI-TOF protein patterns in serum: comparing datasets from different experiments. Bioinformatics. 20, 777–785. - PubMed
    1. Bang, Y.J. , Van Cutsem, E. , Feyereislova, A. , Chung, H.C. , Shen, L. , Sawaki, A. , Lordick, F. , Ohtsu, A. , Omuro, Y. , Satoh, T. , Aprile, G. , Kulikov, E. , Hill, J. , Lehle, M. , Ruschoff, J. , Kang, Y.K. , 2010. Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial. Lancet. 376, 687–697. - PubMed
    1. Bossuyt, P.M. , Reitsma, J.B. , Bruns, D.E. , Gatsonis, C.A. , Glasziou, P.P. , Irwig, L.M. , Moher, D. , Rennie, D. , de Vet, H.C. , Lijmer, J.G. , 2003. The STARD statement for reporting studies of diagnostic accuracy: explanation and elaboration. Ann. Intern. Med.. 138, W1–12. - PubMed

Publication types

Substances